Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
CSP.L Share News (CSP)
CSP Share
Price
CSP Share
News
CSP Share
Chat
CSP Share
Trades
CSP
Live RNS
CSP Share
Charts
CSP Broker
Ratings
CSP Directors
Deals
CSP Financial
Diary
CSP
Fundamentals
CSP Short
Positions
CSP
Media
CSP Company
Research
CSP Company
Timeline
- There is currently no data for CSP
Wednesday broker round-up
Barclays: Berenberg reiterates buy with a target price of 220p.
Aston Martin: Citigroup reiterates buy with a target price of 2,800p.
Segro: JP Morgan reiterates neutral with a target price of 1,195p.
Sainsbury: Barclays reiterates overweight with a target price of 305p.
GlaxoSmithKline: Liberum reiterates buy with a target price of 1,700p.
On The Beach: Liberum reiterates hold with a target price of 380p.
888 Holdings: Peel Hunt reiterates buy with a target price of 500p.
Countryside Properties: Peel Hunt reiterates buy with a target price of 560p.
Redrow: Numis reiterates buy with a target price of 715p.
Accesso: Numis upgrades to buy with a target price of 800p.
International Airlines Group: Credit Suisse reiterates outperform with a target price of 256p.
Centrica: Credit Suisse reiterates outperform with a target price of 70p.
Latest CSP News
- Countryside Properties Has Confident Outlook After Solid Quarter
23 Jan 2020 - DIRECTOR DEALINGS: Countryside Properties Secretary Sells Shares
21 Jan 2020 - UK Earnings, Trading Statements Calendar - Next 7 Days
16 Jan 2020 - UK Shareholder Meetings Calendar - Next 7 Days
16 Jan 2020 - UK BROKER RATINGS SUMMARY: Berenberg Downgrades BP And Raises Shell
14 Jan 2020 - Monday broker round-up
13 Jan 2020 - UK BROKER RATINGS SUMMARY: Peel Hunt Cuts SIG After Profit Warning
9 Jan 2020 - DIRECTOR DEALINGS: Countryside Properties Executive Sells Shares
8 Jan 2020
Related News
GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
* GSK partner Hansoh reports first late-stage data for experimental lung cancer drug
GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...
GSK hails 'milestone' drug trial results in China
(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...
CSP.L News
Countryside Properties Has Confident Outlook After Solid Quarter
Countryside Properties Has Confident Outlook After Solid Quarter
DIRECTOR DEALINGS: Countryside Properties Secretary Sells Shares
DIRECTOR DEALINGS: Countryside Properties Secretary Sells Shares
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Shareholder Meetings Calendar - Next 7 Days
UK Shareholder Meetings Calendar - Next 7 Days
UK BROKER RATINGS SUMMARY: Berenberg Downgrades BP And Raises Shell
UK BROKER RATINGS SUMMARY: Berenberg Downgrades BP And Raises Shell
Monday broker round-up
(Sharecast News) - Avast: JP Morgan upgrades to overweight with a target price of 550p.
UK BROKER RATINGS SUMMARY: Peel Hunt Cuts SIG After Profit Warning
UK BROKER RATINGS SUMMARY: Peel Hunt Cuts SIG After Profit Warning
DIRECTOR DEALINGS: Countryside Properties Executive Sells Shares
DIRECTOR DEALINGS: Countryside Properties Executive Sells Shares
Follow the stocks
